9 results
Summary of the therapeutic uses of adrenergic agonists
Table of Catecholamine Pressors, Non-Catecholamines, Alpha and Beta Receptor
Summary of the therapeutic ... of adrenergic agonists ... Table of Catecholamine ... Therapeutic Uses #Pharmacology ... #Alpha #Beta #Table
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... Summary Mechanisms ... Ozempic), or daily tablet ... #Pharmacology #
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... Summary Mechanisms ... GLP-I receptor agonist ... associated with t risk ... #Summary #DM2 #
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
margin of safety in pharmacology ... the sublingual tablet ... increases the risk ... Pharmacokinetics #Comparison #Table ... #Pharmacology #
Summary of actions of some Cholinergic Agonists

Bethanechol 
• Used in treatment of urinary retention 
• Binds
Summary of actions ... some Cholinergic Agonists ... retention • Binds ... #Pharmacology # ... Table #Summary
Characteristics of Commonly Used Phosphate Binders 
Aluminum 
 - Potent and effective 
 - Useful for
Used Phosphate Binders ... salts - Lower risk ... #Phosphate #Binders ... #Table #Comparison ... #Pharmacology #
Approaching a Difficult Colonoscopy - Scoping Summary
Risk factors for failed C-scope:
 • Incr Age
 • Female
Colonoscopy - Scoping Summary ... Risk factors for ... failed C-scope: ... Water exchange C-scope ... pressure Abdominal Binder
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
nonspecifically binds ... sodium intake; risk ... #medications #pharmacology ... #table #comparison ... #binders
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
Cardiomyopathy - Summary ... Risk Factors and ... during Delivery • Stable ... Bromocriptine, a dopamine agonist ... Risk of recurrence